Literature DB >> 16705711

Novel sequence variants in dysferlin-deficient muscular dystrophy leading to mRNA decay and possible C2-domain misfolding.

Katrin Wenzel1, Miriam Carl, Andreas Perrot, Joanna Zabojszcza, Maziar Assadi, Martin Ebeling, Christian Geier, Peter N Robinson, Wolfram Kress, Karl-Josef Osterziel, Simone Spuler.   

Abstract

Mutations in the gene encoding dysferlin (DYSF) cause the allelic autosomal recessive disorders limb girdle muscular dystrophy 2B and Miyoshi myopathy. It encompasses 55 exons spanning 150 kb of genomic DNA. Dysferlin is involved in membrane repair in skeletal muscle. We identified three families with novel sequence variants in DYSF. All affected family members showed limb girdle weakness and had reduced or absent dysferlin protein on immunohistochemistry. All exons of DYSF were screened by genomic sequencing. Five novel variants in DYSF were found: two missense mutations (c.895G>A and c.4022T>C), one 5' donor splice-site variant (c.855+1delG), one nonsense mutation (c.1448C>A), and a variant in the 3'UTR of DYSF (c.*107T>A). All alterations were confirmed by restriction enzyme analysis and not found in 400 control alleles. Nonsense mediated RNA decay or changes in the three-dimensional protein structure resulting in intracellular dysferlin aggregates and finally the lack of dysferlin protein were identified as consequences of the novel DYSF variants.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16705711     DOI: 10.1002/humu.9424

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  17 in total

Review 1.  Plasma Membrane Repair: A Central Process for Maintaining Cellular Homeostasis.

Authors:  Alisa D Blazek; Brian J Paleo; Noah Weisleder
Journal:  Physiology (Bethesda)       Date:  2015-11

2.  Treatment with Recombinant Human MG53 Protein Increases Membrane Integrity in a Mouse Model of Limb Girdle Muscular Dystrophy 2B.

Authors:  Liubov V Gushchina; Sayak Bhattacharya; Kevin E McElhanon; Jin Hyuk Choi; Heather Manring; Eric X Beck; Jenna Alloush; Noah Weisleder
Journal:  Mol Ther       Date:  2017-07-03       Impact factor: 11.454

3.  Unmasking potential intracellular roles for dysferlin through improved immunolabeling methods.

Authors:  Joseph A Roche; Lisa W Ru; Andrea M O'Neill; Wendy G Resneck; Richard M Lovering; Robert J Bloch
Journal:  J Histochem Cytochem       Date:  2011-11       Impact factor: 2.479

Review 4.  Translational research and therapeutic perspectives in dysferlinopathies.

Authors:  Florian Barthélémy; Nicolas Wein; Martin Krahn; Nicolas Lévy; Marc Bartoli
Journal:  Mol Med       Date:  2011-05-06       Impact factor: 6.354

5.  Dysfunction of dysferlin-deficient hearts.

Authors:  Katrin Wenzel; Christian Geier; Fatimunnisa Qadri; Norbert Hubner; Herbert Schulz; Bettina Erdmann; Volkmar Gross; David Bauer; Ralf Dechend; Rainer Dietz; Karl Josef Osterziel; Simone Spuler; Cemil Ozcelik
Journal:  J Mol Med (Berl)       Date:  2007-09-09       Impact factor: 4.599

6.  [Amyloidosis in muscular dystrophy].

Authors:  M Carl; C Röcken; S Spuler
Journal:  Pathologe       Date:  2009-05       Impact factor: 1.011

7.  Late-onset myopathy of the posterior calf muscles mimicking Miyoshi myopathy unrelated to dysferlin mutation: a case report.

Authors:  Clemens Neusch; Tanja Kuhlmann; Wolfram Kress; Christiane Schneider-Gold
Journal:  J Med Case Rep       Date:  2012-10-10

8.  Proteomic analysis of the dysferlin protein complex unveils its importance for sarcolemmal maintenance and integrity.

Authors:  Antoine de Morrée; Paul J Hensbergen; Herman H H B M van Haagen; Irina Dragan; André M Deelder; Peter A C 't Hoen; Rune R Frants; Silvère M van der Maarel
Journal:  PLoS One       Date:  2010-11-05       Impact factor: 3.240

9.  Muscular dystrophy with marked Dysferlin deficiency is consistently caused by primary dysferlin gene mutations.

Authors:  Mafalda Cacciottolo; Gelsomina Numitone; Stefania Aurino; Imma Rosaria Caserta; Marina Fanin; Luisa Politano; Carlo Minetti; Enzo Ricci; Giulio Piluso; Corrado Angelini; Vincenzo Nigro
Journal:  Eur J Hum Genet       Date:  2011-04-27       Impact factor: 4.246

10.  Dysferlin-peptides reallocate mutated dysferlin thereby restoring function.

Authors:  Verena Schoewel; Andreas Marg; Severine Kunz; Tim Overkamp; Romy Siegert Carrazedo; Ute Zacharias; Peter T Daniel; Simone Spuler
Journal:  PLoS One       Date:  2012-11-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.